Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects



Status:Recruiting
Conditions:Neurology, Neurology, Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - 90
Updated:2/10/2019
Start Date:April 2015
End Date:April 2019
Contact:Leah Forsberg, Ph.D.
Email:forsberg.leah@mayo.edu
Phone:507-293-5551

Use our guide to learn which trials are right for you!

This study is being done to learn more about normal thinking and behavior, mild thinking and
behavior problems, Frontotemporal Dementia and other forms of dementia in families in which
one or more relatives have a mutation associated with Frontotemporal Dementia.

This multicenter study will enroll 300 members of familial Frontotemporal Dementia (FTD)
families across 8 experienced FTD research centers with a known mutation in MAPT, PGRN, or
C9ORF72 (100 mutation carriers with mild dementia or minimally symptomatic yet non-demented,
100 asymptomatic mutation carriers, and 100 clinically normal relatives who are non-mutation
carriers) to obtain annual assessments including T1-MRI, FLAIR, diffusion tensor imaging
(DTI), ASL perfusion (ASLp), intrinsic connectivity functional MRI (icfMRI), MR spectroscopy
(MRS), CSF, blood, and behavioral, neuropsychological and functional assessment, for a total
of three assessments per participant.

A primary goal of this study is to identify the most robust and reliable methods to track
disease progression in familial FTD so that disease-modifying therapeutic trials can be
designed appropriately.

Inclusion Criteria:

1. Must be a member of family with a known mutation in one of the three major FTLD
related genes: MAPT, PGRN, or C9ORF72.

2. At least 18 years of age.

3. The predominant phenotype in the kindred must be cognitive/behavioral (ie, kindreds in
whom parkinsonism or ALS is the predominant clinical phenotype among affected
relatives may be excluded)

4. Have a reliable informant who personally speaks with or sees that subject at least
weekly.

5. Subject is sufficiently fluent in English to complete all measures

6. Subject must be willing and able to consent to the protocol and undergo yearly
evaluations over 3 years.

7. Subject must be willing and able to undergo neuropsychological testing (at least at
baseline visit).

8. Subject must have no contraindication to MRI imaging.

Exclusion Criteria

1. Known presence of a structural brain lesion (e.g. tumor, cortical infarct).

2. Presence of another neurologic disorder which could impact findings (eg, multiple
sclerosis).

3. Subject is unwilling to return for follow-up yearly, undergo neuropsychological
testing and MR imaging.

4. Subject has no reliable informant.
We found this trial at
8
sites
Rochester, Minnesota 55905
Principal Investigator: Bradley Boeve, MD
Phone: 507-293-5551
?
mi
from
Rochester, MN
Click here to add this to my saved trials
116th St and Broadway
New York, New York 10027
(212) 854-1754
Principal Investigator: Edward Huey, MD
Columbia University In 1897, the university moved from Forty-ninth Street and Madison Avenue, where it...
?
mi
from
New York, NY
Click here to add this to my saved trials
Charlestown, Massachusetts 02129
Principal Investigator: Bradford Dickerson, MD
Phone: 617-726-6205
?
mi
from
Charlestown, MA
Click here to add this to my saved trials
4500 San Pablo Rd S
Jacksonville, Florida 32224
(904) 953-2000
Principal Investigator: Neill Graff-Radford, MD
Phone: 904-953-9680
Mayo Clinic Florida Thousands of people come to Mayo Clinic in Jacksonville, Fla., annually for...
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
Principal Investigator: Murray Gossman, MD
Phone: 215-349-5873
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Saint Louis, Missouri 63110
Principal Investigator: Nupur Ghoshal, MD, PhD
Phone: 314-362-3839
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
San Francisco, California 94358
Principal Investigator: Howard Rosen, MD
Phone: 415-476-0670
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
Vancouver, British Columbia V6T 1W5
Principal Investigator: Ging-Yeuk Hsiung, MD
Phone: 604 822 7989
?
mi
from
Vancouver,
Click here to add this to my saved trials